Open AccessRucaparib Improves PFS in BRCA-Mutant Recurrent Ovarian Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2017
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000527174.57408.58
Subject(s) - ovarian cancer , brca mutation , parp inhibitor , medicine , oncology , cancer , cancer research , chemotherapy , poly adp ribose polymerase , biology , genetics , dna , polymerase